BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

27 related articles for article (PubMed ID: 2384130)

  • 1. Microarray analysis reveals distinct gene expression patterns in the mouse cortex following chronic neuroleptic and stimulant treatment: implications for body weight changes.
    Mehler-Wex C; Grünblatt E; Zeiske S; Gille G; Rausch D; Warnke A; Gerlach M
    J Neural Transm (Vienna); 2006 Oct; 113(10):1383-93. PubMed ID: 16465460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of long-term antipsychotic treatment on NMDA receptor binding and gene expression of subunits.
    Schmitt A; Zink M; Müller B; May B; Herb A; Jatzko A; Braus DF; Henn FA
    Neurochem Res; 2003 Feb; 28(2):235-41. PubMed ID: 12608697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of action of atypical antipsychotic drugs: a critical analysis.
    Kinon BJ; Lieberman JA
    Psychopharmacology (Berl); 1996 Mar; 124(1-2):2-34. PubMed ID: 8935797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-induced oral dyskinesias in rats after traditional and new neuroleptics.
    Kakigi T; Gao XM; Tamminga CA
    J Neural Transm Gen Sect; 1995; 101(1-3):41-9. PubMed ID: 8695056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of chronic trifluoperazine administration and subsequent withdrawal on the production and persistence of perioral behaviours in two rat strains.
    Collins P; Broekkamp CL; Jenner P; Marsden CD
    Psychopharmacology (Berl); 1993; 112(4):437-44. PubMed ID: 7871054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroleptic-induced vacuous chewing movements in rodents: incidence and effects of long-term increases in haloperidol dose.
    Egan MF; Hyde TM; Kleinman JE; Wyatt RJ
    Psychopharmacology (Berl); 1995 Jan; 117(1):74-81. PubMed ID: 7724705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clozapine. A review of its pharmacological properties, and therapeutic use in schizophrenia.
    Fitton A; Heel RC
    Drugs; 1990 Nov; 40(5):722-47. PubMed ID: 2292234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoradiographic analysis of regional alterations in brain receptors following chronic administration and withdrawal of typical and atypical neuroleptics in rats.
    See RE; Toga AW; Ellison G
    J Neural Transm Gen Sect; 1990; 82(2):93-109. PubMed ID: 1977417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spontaneous orofacial movements in rodents induced by long-term neuroleptic administration: a second opinion.
    Ellison G
    Psychopharmacology (Berl); 1991; 104(3):404-8. PubMed ID: 1681559
    [No Abstract]   [Full Text] [Related]  

  • 10. Clozapine: neuroleptic-induced EPS and tardive dyskinesia.
    Casey DE
    Psychopharmacology (Berl); 1989; 99 Suppl():S47-53. PubMed ID: 2682732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expected incidence of tardive dyskinesia associated with atypical antipsychotics.
    Glazer WM
    J Clin Psychiatry; 2000; 61 Suppl 4():21-6. PubMed ID: 10739327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of chronic administration of haloperidol and the atypical neuroleptics, clozapine and raclopride, in an animal model of tardive dyskinesia.
    See RE; Ellison G
    Eur J Pharmacol; 1990 Jun; 181(3):175-86. PubMed ID: 2384130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intermittent and continuous haloperidol regimens produce different types of oral dyskinesias in rats.
    See RE; Ellison G
    Psychopharmacology (Berl); 1990; 100(3):404-12. PubMed ID: 2315437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dose-response characteristics of rat oral dyskinesias with chronic haloperidol or clozapine administration.
    Gao XM; Hashimoto T; Cooper TB; Tamminga CA
    J Neural Transm (Vienna); 1997; 104(1):97-104. PubMed ID: 9085197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic haloperidol, but not clozapine, produces altered oral movements and increased extracellular glutamate in rats.
    See RE; Chapman MA
    Eur J Pharmacol; 1994 Oct; 263(3):269-76. PubMed ID: 7843264
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.